Markets · Global Equities · US
ABEONA THERAPEUTICS INC. ABEO
Exchange Nasdaq. Sector Pharma & biotech. Source: SEC companyfacts. Not a price feed.
- Revenue TTM 24.00M
- EBITDA TTM -80.91M
- Net debt -131.84M
- ND/EBITDA 1.63
- EBITDA/interest -23.9
- ROE 0.52
- Implied band B